Exercise Therapy for Parkinson's Disease
Trial Summary
What is the purpose of this trial?
This study will investigate the impact of two common exercise modalities, cardiovascular and resistance training, on sleep quality and architecture in persons with Parkinson's disease (PD), and whether these potential positive changes in sleep are associated with improvements in brain plasticity and different quality of life (QoL)-related aspects. Participants will perform either cardiovascular training (CT) or resistance training (RT) for 12 weeks, at least two times/week. The assessments will be performed at baseline and after training by an assessor blinded to the participants' group allocation.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it requires that you have been on a stable dosage of medication for the past month.
What data supports the effectiveness of the treatment Exercise Therapy for Parkinson's Disease?
Is exercise therapy safe for people with Parkinson's Disease?
Exercise therapy, including resistance and aerobic training, is generally safe for people with various health conditions, including heart disease and hypertension. Studies show that these exercises can improve muscle strength and cardiovascular health with minimal risk when done under proper guidance.678910
How does exercise therapy differ from other treatments for Parkinson's disease?
Exercise therapy, including cardiovascular and resistance training, is unique for Parkinson's disease as it focuses on improving physical function, balance, and strength through structured physical activity rather than medication. This approach can enhance quality of life and functional capacity without the side effects associated with drugs, making it a beneficial adjunct to traditional treatments.13111213
Eligibility Criteria
This trial is for people with mild to moderate Parkinson's Disease who have poor sleep quality but are on stable medication. They should not be in other drug/exercise trials, have severe untreated sleep apnea, dementia or conditions that prevent exercise. A score >18 on PDSS-2 and <21 on MoCA excludes them.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants perform either cardiovascular training or resistance training for 12 weeks, at least two times per week
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Cardiovascular Training
- Resistance Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
McGill University
Lead Sponsor
Jewish Rehabilitation Hospital
Collaborator